Reply: Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia
- PMID: 36965960
- DOI: 10.1016/j.jacl.2023.03.001
Reply: Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia
Conflict of interest statement
Conflict of Interest Statement AA: None CMB: Grant/Research Support- All significant. (All paid to institution, not individual): Abbott Diagnostic, Akcea, Amgen, Arrowhead, Esperion, Ionis, Merck, New Amsterdam, Novartis, Novo Nordisk, Regeneron, Roche Diagnostic, NIH, AHA, ADA.Consultant- 89Bio, Abbott Diagnostics, Alnylam Pharmaceuticals, Althera, Amarin, Amgen, Arrowhead, Astra Zeneca, Denka Seiken*, Esperion, Genentech, Gilead, Illumina, Ionis, Matinas BioPharma Inc, Merck, New Amsterdam*, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic *Significant where noted (>$10,000); remainder modest (<$10,000). ACG: Research contracts— Arrowhead, NewAmsterdam, Novartis, Regeneron, Sanofi-Aventis, Pfizer, Amgen, IONIS/Akcea, Esperion, (all grants to medical school). Consulting—Novartis, Akcea, Esperion, Regeneron, IONIS, NewAmsterdam.
Comment on
-
Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.J Clin Lipidol. 2023 Jan-Feb;17(1):150-156. doi: 10.1016/j.jacl.2022.11.009. Epub 2022 Nov 22. J Clin Lipidol. 2023. PMID: 36470719
-
Letter regarding the article Sex-Related Differences in Premature Cardiovascular Disease in Familial Hypercholesterolemia.J Clin Lipidol. 2023 Mar-Apr;17(2):303. doi: 10.1016/j.jacl.2023.02.006. J Clin Lipidol. 2023. PMID: 36965959 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources